Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Liabilities and Shareholders Equity (2021 - 2025)

Historic Liabilities and Shareholders Equity for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $111.3 million.

  • Biote's Liabilities and Shareholders Equity rose 994.75% to $111.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $461.9 million, marking a year-over-year decrease of 935.8%. This contributed to the annual value of $122.4 million for FY2024, which is 2120.16% down from last year.
  • Biote's Liabilities and Shareholders Equity amounted to $111.3 million in Q3 2025, which was up 994.75% from $104.8 million recorded in Q2 2025.
  • Biote's Liabilities and Shareholders Equity's 5-year high stood at $319.0 million during Q1 2021, with a 5-year trough of $54.3 million in Q4 2021.
  • For the 5-year period, Biote's Liabilities and Shareholders Equity averaged around $160.2 million, with its median value being $122.4 million (2024).
  • Within the past 5 years, the most significant YoY rise in Biote's Liabilities and Shareholders Equity was 10549.42% (2022), while the steepest drop was 6556.69% (2022).
  • Biote's Liabilities and Shareholders Equity (Quarter) stood at $54.3 million in 2021, then skyrocketed by 105.49% to $111.6 million in 2022, then soared by 39.1% to $155.3 million in 2023, then fell by 21.2% to $122.4 million in 2024, then fell by 9.03% to $111.3 million in 2025.
  • Its Liabilities and Shareholders Equity was $111.3 million in Q3 2025, compared to $104.8 million in Q2 2025 and $123.4 million in Q1 2025.